These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15755266)

  • 1. Non-steroidal anti-inflammatory drugs and proton-pump inhibitors vs. cyclo-oxygenase-2 selective inhibitors in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
    Chan FK
    Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():5-6, 21-4. PubMed ID: 15755266
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
    Thomsen RW; Riis A; Christensen S; McLaughlin JK; Sørensen HT
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1431-8. PubMed ID: 17032286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The appropriate use of proton-pump inhibitor co-therapy with non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors.
    Lanas A
    Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():2-4, 21-4. PubMed ID: 15755265
    [No Abstract]   [Full Text] [Related]  

  • 4. Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding.
    Lanas A
    N Engl J Med; 2003 Jun; 348(24):2464-6; author reply 2464-6. PubMed ID: 12802035
    [No Abstract]   [Full Text] [Related]  

  • 5. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
    Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer.
    Christensen S; Riis A; Nørgaard M; Thomsen RW; Sørensen HT
    Aliment Pharmacol Ther; 2007 Apr; 25(8):907-12. PubMed ID: 17402994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.
    Chan FK; Wong VW; Suen BY; Wu JC; Ching JY; Hung LC; Hui AJ; Leung VK; Lee VW; Lai LH; Wong GL; Chow DK; To KF; Leung WK; Chiu PW; Lee YT; Lau JY; Chan HL; Ng EK; Sung JJ
    Lancet; 2007 May; 369(9573):1621-6. PubMed ID: 17499604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of prevention.
    Scheiman JM
    Rev Gastroenterol Disord; 2005; 5 Suppl 2():39-49. PubMed ID: 16369226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A
    Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
    Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].
    MMW Fortschr Med; 2004 Mar; 146(13):61. PubMed ID: 15219139
    [No Abstract]   [Full Text] [Related]  

  • 14. [In high risk patients cyclooxygenase inhibitor plus proton pump inhibitor].
    Bolten WW
    MMW Fortschr Med; 2003 Jan; 145(5):9. PubMed ID: 12619199
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical treatment of stomach ulcer except in emergency].
    Bretagne JF
    Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S73-S80. PubMed ID: 8734374
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
    MMW Fortschr Med; 2004 May; 146(22):48. PubMed ID: 15373113
    [No Abstract]   [Full Text] [Related]  

  • 17. Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis.
    Sørensen HT; Jacobsen J; Nørgaard M; Pedersen L; Johnsen SP; Baron JA
    Aliment Pharmacol Ther; 2006 Jul; 24(1):111-6. PubMed ID: 16803609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drugs: who should receive prophylaxis?
    Hawkey CJ
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():59-64. PubMed ID: 15335414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
    Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM
    Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper gastrointestinal complications related to non-steroidal anti-inflammatory drugs--what have we achieved so far?
    Wong VW; Leong RW; Chan FK
    Dig Liver Dis; 2004 Jan; 36(1):1-3. PubMed ID: 14971808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.